Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.10.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Operating expenses:    
Research and development $ 1,421,482 $ 165,750
General and administrative 989,748 815,106
Total operating expenses 2,411,230 980,856
Loss from operations (2,411,230) (980,856)
Other income (expenses):    
Change in fair value of derivative liabilities (318,541) (5,702)
Interest income (expense), net (650,322) 2,522
Other income 2,350
Total other income (expenses) (968,863) (830)
Net loss $ (3,380,093) $ (981,686)
Net loss per common share - basic and diluted $ (0.27) $ (0.08)
Weighted average number of common shares outstanding - basic and diluted 12,549,870 12,532,840